Boryung Pharmaceutical Co., Ltd
169
21
23
124
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.4%
4 terminated/withdrawn out of 169 trials
96.9%
+10.4% vs industry average
23%
39 trials in Phase 3/4
7%
9 of 124 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (169)
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
Role: collaborator
An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety
Role: lead
Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes
Role: collaborator
Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)
Role: collaborator
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Role: collaborator
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions
Role: lead
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions
Role: lead
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions
Role: lead
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions
Role: lead
A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
Role: lead
A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.
Role: lead
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Role: lead
A Study of Olanzapine in Participants With Bipolar Disorder.
Role: lead
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
Role: lead
Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection
Role: lead
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Role: lead
A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
Role: lead
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Role: lead
An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Role: lead
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Role: lead